Avalon Trust’s Transmedics TMDX Stock Holding History

Avalon Trust’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-75	Closed	-$7.46K	–	482
2026 Q1	$7.46K	Hold	75	–	–	﹤0.01%	413
2025 Q4	$9.12K	Buy	+75	New	+$9.41K	﹤0.01%	381

Other funds holding TMDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Avalon Trust's TMDX Position: Q2 2026 in Review

Avalon Trust sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 75 shares — an estimated $7.46K sold.

Avalon Trust first reported a position in TMDX in Q4 2025 and held it in 2 quarters. The position peaked at $9.12K in Q4 2025. 375 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

Avalon Trust reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
Avalon Trust sold 75 Transmedics shares in Q2 2026, an estimated $7.46K.
Avalon Trust first reported a position in Transmedics in Q4 2025 and held it in 2 quarters.
Avalon Trust's Transmedics position peaked at $9.12K in Q4 2025.
375 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Avalon Trust's 13F filing for Q2 2026, filed 6 Aug 2026.